Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
ASSETS
Cash and cash equivalents	$ 23,655	$ 40,916
Restricted cash	2,017	2,566
Accounts receivable	2,602	2,087
Note receivable	2,776	2,552
Due from related parties	18,871	13,124
Investment in unconsolidated subsidiaries	2,031	1,803
Prepaid expense and other assets	4,055	4,759
Property and equipment, net	1,149	981
Right-of-use assets	14,193	14,789
Deferred tax assets, net	42,847	45,151
Intangibles, net	122,642	128,788
Goodwill	418,690	418,701
Total assets	655,528	676,217
LIABILITIES:
Accounts payable	742	401
Accrued expenses	10,714	12,474
Due to related parties	405	2,258
Other liabilities	13,727	1,808
Contingent consideration	23,090	22,963
Deferred revenues	11,929	12,953
Lease liabilities	15,296	15,700
Debt obligations	187,690	212,496
Total liabilities	263,593	281,053
COMMITMENTS AND CONTINGENCIES (NOTE 14)
STOCKHOLDERS' EQUITY:
Treasury stock	(273)	(273)
Additional paid-in-capital	639,384	650,405
Accumulated deficit	(247,293)	(255,085)
Total stockholders' equity	391,935	395,164
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	655,528	676,217
Class A Common Stock
STOCKHOLDERS' EQUITY:
Common stock value	35	34
Class B Common Stock
STOCKHOLDERS' EQUITY:
Common stock value	$ 82	$ 83